Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Giving Device PIPEs A Good Twist

This article was originally published in Start Up

Executive Summary

According to Elsevier's Strategic Transactions, venture capital firms participated in 11 private investments in public entities in the two years prior to the economic collapse versus making 12 PIPEs in the two years that followed. Although it's too early to judge, hesitation may be warranted. Venture investors saw gains in only seven of the 12 deals.

You may also be interested in...



Medtech PIPE Volume, Share Gains Indicate Rebound In Private Investments

A new analysis of medtech PIPE deals in Informa’s Strategic Transactions and PlacementTracker shows a rebound in transaction and dollar volume.

The A-List: 2010's Trend-Shaping Series A Financings

Investments for start-ups seeking their first infusion of venture capital continues to be scarce as venture firms seek later-stage opportunities and liquidity to improve their own chances of raising new funds.

The A-List: 2010's Trend-Shaping Series A Financings

Investments for start-ups seeking their first infusion of venture capital continues to be scarce as venture firms seek later-stage opportunities and liquidity to improve their own chances of raising new funds.

Topics

Related Companies

Related Deals

Latest Headlines
See All
UsernamePublicRestriction

Register

MT037640

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel